Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

0.6876
-0.0854-11.05%
Post-market: 0.70000.0124+1.80%19:39 EDT
Volume:133.89K
Turnover:95.24K
Market Cap:2.67M
PE:-0.07
High:0.7800
Open:0.7800
Low:0.6715
Close:0.7730
52wk High:24.30
52wk Low:0.6715
Shares:3.88M
Float Shares:3.81M
Volume Ratio:1.50
T/O Rate:3.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.10
PE(LYR):-0.05

Loading ...

Sunshine Biopharma Plans up to $4 Million At-the-market Share Sale Via Aegis Capital

Reuters
·
Jul 21

Sunshine Biopharma announces publication of new results on MR1-114

TIPRANKS
·
Jul 20

Sunshine Biopharma Says Study Shows Mr1-114 Sars-cov-2 Inhibitor Effective in Mice, Potent in Vitro Across Variants

Reuters
·
Jul 20

Sunshine Biopharma Announces Release of Research Findings Press Statement

Reuters
·
Jul 20

Sunshine Biopharma Settles Dispute with Former Nora Pharma President for CAD 1.5 Million

Reuters
·
Jul 11

Sunshine Biopharma Wins Canadian Approval for Generic Arimidex Tablet

Reuters
·
Jun 25

Sunshine Biopharma shareholders OK Nasdaq-related approval provisions for Series C warrants from $6 million offering

Reuters
·
Jun 09

Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets

Reuters
·
Jun 01

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM

Reuters
·
Jun 01

NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

Reuters
·
May 30

Sunshine Biopharma Inc trading halted, news pending

TIPRANKS
·
May 30

Sunshine Biopharma shareholder approved discounted share issuance above 20% Nasdaq limit

Reuters
·
May 30

Sunshine Biopharma files draft information statement on warrant approval provisions

Reuters
·
May 30

Sunshine Biopharma wins US patent for coronavirus treatment technology

Reuters
·
May 29

Sunshine Biopharma executes 1-for-10 reverse stock split effective June 1 to maintain Nasdaq listing

Reuters
·
May 28

Sunshine Biopharma wins Canadian approval for generic amoxicillin

Reuters
·
May 21

Sunshine Biopharma prices USD 6 million public offering at USD 0.5 per unit

Reuters
·
May 19

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM

Reuters
·
May 18

Sunshine Biopharma Q1 FY26 net loss widens to $1.24 million; sales fall 9.1% to $8.09 million

Reuters
·
May 14

Sunshine Biopharma files to sell 5.825M common units

TIPRANKS
·
May 13